A Novel IL6 Antibody Sensitizes Multiple Tumor Types to Chemotherapy Including Trastuzumab-Resistant Tumors.
about
Properties and feasibility of using cancer stem cells in clinical cancer treatment.Identification of serum inflammatory markers as classifiers of lung cancer mortality for stage I adenocarcinoma.Senescence-Inflammatory Regulation of Reparative Cellular Reprogramming in Aging and Cancer.IL6 Receptor Blockade Enhances Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma.Targeting the IL-6/JAK/STAT3 signalling axis in cancer.Exogenous IL6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild-type, African American PCa cells.
P2860
A Novel IL6 Antibody Sensitizes Multiple Tumor Types to Chemotherapy Including Trastuzumab-Resistant Tumors.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A Novel IL6 Antibody Sensitize ...... Trastuzumab-Resistant Tumors.
@en
type
label
A Novel IL6 Antibody Sensitize ...... Trastuzumab-Resistant Tumors.
@en
prefLabel
A Novel IL6 Antibody Sensitize ...... Trastuzumab-Resistant Tumors.
@en
P2093
P1433
P1476
A Novel IL6 Antibody Sensitize ...... g Trastuzumab-Resistant Tumors
@en
P2093
April Davis
David A Tice
Elaine Hurt
Haihong Zhong
Jacques Moisan
Jiaqi Huang
Max S Wicha
Michael Fung
Robert E Hollingsworth
P304
P356
10.1158/0008-5472.CAN-15-0883
P407
P577
2016-01-07T00:00:00Z